Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial

J Infect. 2023 May;86(5):e120-e122. doi: 10.1016/j.jinf.2023.03.004. Epub 2023 Mar 6.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcifediol*
  • ChAdOx1 nCoV-19*
  • Dietary Supplements
  • Humans
  • Prospective Studies
  • Vaccination

Substances

  • ChAdOx1 nCoV-19
  • Calcifediol